A new bilateral trade agreement between the United States and Tonga has reduced tariffs on medicaments, including those for the digestive system (HS Code: 3004.90), facilitating increased exports from the US to Tonga.
2023-10-15
Impact: Positive impact with expected growth in US exports of digestive system medicaments to Tonga due to lower tariffs.
Tonga Imposes New Import Regulations on Medicaments
Tonga has introduced stricter import regulations for medicaments, requiring additional certification for digestive system drugs imported from the US to ensure compliance with local health standards.
2023-09-01
Impact: Potential delays in trade due to increased regulatory requirements, which may temporarily reduce US exports.
US Pharmaceutical Company Expands Market in Tonga
A major US pharmaceutical company specializing in digestive system medicaments has entered the Tongan market, signing a distribution deal with local partners to meet growing demand.
2023-08-20
Impact: Likely increase in trade volume of digestive system medicaments from the US to Tonga as market access improves.
Policy Updates
US-Tonga Tariff Reduction on Medicaments
Under a new trade pact, tariffs on medicaments primarily affecting the digestive system (HS Code: 3004.90) have been reduced by 15% for imports from the US to Tonga, effective immediately.
Date: 2023-10-10
Tonga Updates Health Import Standards
Tonga has updated its health import standards, mandating additional safety certifications for all imported medicaments, including those for digestive system treatments, impacting US exporters.
